Na June 16-17, 2023, MedGence sonyeere na ogbako on High-Quality Development of Healthcare Industry & the 8th Summit for China Pharmaceutical R&D Innovation, nke emere nke ọma na Chongqing.
A sọpụrụ MedGence dị ka otu n'ime "2023 Top 20 R&D CRO Enterprises na China"!
Nke mbụ, na mmemme mmeghe, ewepụtara usoro ndepụta nke "2022 China Pharmaceutical R&D Strength Ranking" wee sọpụrụ MedGence dịka otu n'ime "2023 Top 20 Pharmaceutical CRO Enterprises na China"!
The "2023 Pharmaceutical CRO Enterprises in China" bụ onye CRO Ranking Expert Review Committee ahọpụtara dabere na ihe ngosi 10 na ọtụtụ akụkụ, dị ka mkpokọta ego kwa afọ (ego ọrụ), uto ego ha nwetara kwa afọ (%), uru net, uto net (%), R&D itinye ego, R&D itinye ego (%), nha ndị ọrụ, nha ndị ọrụ, uto nha, akara, wdg. otu nkwụsị TCM ụlọ ọrụ mmepe ọgwụ ọhụrụ, meriri ihe nrite "2023 Top 20 Pharmaceutical CRO Enterprises na China", gosipụtara ike na ike ya.
Ka ọ dị ugbu a, dị ka onye ndu nke TCM CXO, Dr. Yi Yueneng, Onye isi oche & onye isi nchịkwa nke MedGence, ka a kpọrọ ya ka ọ bịa nnọkọ nke asatọ maka China Pharmaceutical R & D Innovation ma kwuo okwu na "Malite na njedebe - Strategies for Development of New Chinese Medicine". O mere ka ọ pụta ìhè na ka ọ dị ugbu a, a na-emewanyewanyewanye usoro mmepe nke nkà mmụta ọgwụ ndị China, na-emeziwanye gburugburu ebe obibi amụma na nkwado ahụ na-abawanye, na nkà mmụta ọgwụ ndị China ebutewo n'ọgbọ ọla edo. Ọ hazikwara gburugburu amụma, usoro nyocha na mmepe, na ọnọdụ itinye n'ọrụ nke mmepe nke ụlọ ọrụ ọgwụ ndị China ọdịnala n'oge ọhụrụ, gosipụtara mmekọrịta ezi uche dị n'ime, nyochaa nsogbu ndị pụtara ìhè nke ka dị na mmepe ugbu a nke ụlọ ọrụ ọgwụ ọdịnala ndị China, ma tụpụta usoro mgbochi ndị nwere ike ime.
Mgbe ahụ, Dr. Yi Yueneng, dị ka onye ọbịa nke roundtable forum on "Is the Spring of Chinese Medicine New Product R&D Coming", jikọtara ọnụ na-atụle ọnọdụ na ihe ịma aka nke R&D na ọhụrụ nke nkà mmụta ọgwụ Chinese na ụlọ ọrụ egwuregwu. Dị ka onye na-emekọ ihe ọnụ, MedGence gbanyere mkpọrọgwụ na ụlọ ọrụ ọgwụ, na-eme nchọpụta na-arụsi ọrụ ike, na-emepe emepe mgbe niile, na-akwalite mmepe nke ụlọ ọrụ ahụ, na-aga n'ihu na-eje ozi na ụlọ ọrụ ọgwụ na gburugburu China.
The nzuko dọtara ọtụtụ ndị ndú na ubi nke ọgwụ ụkpụrụ, kọleji na mahadum, nnyocha institutes, ọgwụ ụlọ ọrụ, R & D nkeji na ọtụtụ ndị ọzọ elites isonye na thematic akụkọ gburugburu R & D nke omenala Chinese ọgwụ, nkwadebe ọhụrụ, ụkpụrụ na atumatu, àgwà na nchekwa, usoro njikarịcha, ọhụrụ ngwá, ọhụrụ teknụzụ na ndị ọzọ hotspots, na otu n'ime ndị ọzọ na-ekpo ọkụ n'oge elu ugwu, na otu n'ime ndị kasị ewu ewu. nke ndị ngosi pụrụ iche nke ihe omume ahụ, nwere ụlọ ntu pụrụ iche, nke dọtara ọtụtụ ndị ọrụ ibe na ụlọ ọrụ ahụ ileta! N'oge nzuko, dị ka otu n'ime ndị ngosi a kpọrọ, Enable Pharma nwere ụlọ ntu pụrụ iche, nke dọtara ọtụtụ ndị ọrụ ụlọ ọrụ ka ha gaa na ụlọ ntu maka ntụle, nkwurịta okwu chiri anya na ndị isi ụlọ ọrụ na-emepụta ọgwụ, na ịkwụsị ọchịchọ maka nyocha na mmepe ọgwụ.
Oge nzipu: Jul-15-2023